Online Trial Tracker - Larvol Sigma

Ritucad (rituximab biosimilar) / Cadila, Novavax

Phase 1

Welcome, Profile Billing Logout

1 Trials

All TrialsIndustry lead sponsorIndustry collaboratorPhase 1

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Ritucad (rituximab biosimilar) / Cadila

rituximabNovCad: A randomized controlled study to evaluate pharmacokinetic, pharmacodynamic (efficacy) and safety of Rituximab (Zydus) and Rituximab (Roche) in patients with Rheumatoid Arthritis

Recruiting

RoW

Cadila Healthcare Limited

Rheumatoid Arthritis

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites